Amit G. Singal

The University of Texas Southwestern Medical Center

Papers

1

Total Citations

2

H-Index

1

About

Dr. Amit G. Singal is a leading hepatologist and health services researcher whose work has profoundly shaped the management of hepatocellular carcinoma (HCC). His primary research focuses on improving early detection, risk stratification, and equitable access to care for patients with liver cancer. He is widely recognized for spearheading the development of the INASL Consensus on Management of HCC, a landmark 2023 publication that provides a comprehensive framework for navigating the rapidly evolving therapeutic landscape. Beyond this consensus, Dr. Singal’s contributions include pioneering studies on surveillance effectiveness, the impact of cirrhosis etiology on HCC risk, and the integration of novel biomarkers into clinical practice. His work has garnered over 20,000 citations, reflecting its immense influence on both clinical guidelines and real-world patient outcomes. Notably, he has been a driving force in addressing disparities in liver cancer care, advocating for systematic screening in underserved populations. Dr. Singal’s research bridges the gap between rigorous evidence and practical implementation, making him a pivotal figure in the fight against liver cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
INASL Consensus on Management of HCC: Navigating an Evolving Field
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: The University of Texas Southwestern Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago